Advertisement Quintiles partners with Scottish Health Boards to advance clinical research - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Quintiles partners with Scottish Health Boards to advance clinical research

Quintiles has partnered with Aberdeen, Dundee, Edinburgh and Glasgow teaching health boards to accelerate clinical research and improve health outcomes.

The partnership, a part of its Prime Site program, is designed to increase access to clinical trials for both patients and investigators, quickening the collection of data about the safety and efficacy of investigational therapies.

The Scottish government’s chief scientist office is focused on metrics.

Quintiles Integrated Site Services Lindy Jones said, "This partnership will further enhance our ability to recruit patients and investigators – two groups critical to an efficient and effective drug development process."

Pursuant to the partnership, Quintiles will launch new technology that uses electronic health records to improve the identification of patients for potential inclusion in clinical research.

Scotland Cabinet Secretary for Health and Well-Being Alex Neil said, "These developments demonstrate the importance that we place on research within NHS Scotland, and will help to further enhance Scotland’s growing reputation as a global centre of excellence for clinical research."